(Press-News.org)
The National Foundation for Cancer Research (NFCR) is proud to announce that both the organization and our CEO, Dr. Sujuan Ba, have been honored with the "2024 Pioneer in Medicine Award" by the World Brain Mapping Foundation and the Society for Brain Mapping and Therapeutics. The award was presented to Dr. Ba at the 21st Annual GFC Awards Gala on Friday, March 15th, 2024. This recognition highlights a significant landmark in NFCR's over 50 years of impact in charting new pathways through research to find cures for cancer and its leadership in the global fight against cancer.
The World Brain Mapping Foundation's Annual "Gathering for Cure" Gala is designed to recognize pioneers in medicine and science and celebrate their achievements, especially in brain mapping, health policy, neuroscience, and mental health philanthropy. Dr. Ba and NFCR have made significant commitments and contributions to combating Glioblastoma (GBM), one of the deadliest brain cancers.
Dr. Ba and NFCR have been at the forefront and leading supporters of creating the revolutionary clinical trial platform, GBM AGILE (Glioblastoma Adaptive Innovative Learning Environment), a paradigm-shifting clinical trial system to speed up the clinical trial process to bring new treatments and drugs to brain patients.
NFCR was also the first founding partner for the Global Coalition for Adaptive Research (GCAR), which Dr. Ba co-founded with a group of dedicated brain cancer researchers, clinicians, and patient advocates. GCAR operationalizes the GBM AGILE, now open at 60 sites in 6 countries, with six new agents in the system and more to come soon. GBM AGILE has screened over 1900 patients as of today, giving new hope to GBM patients.
Furthermore, this platform is not only transforming the landscape of glioblastoma treatment but also extending the innovative approach to other deadly cancers, such as pancreatic cancer and ovarian cancer.
Reflecting on NFCR's 51-year-long journey to make cures possible, Dr. Ba said: "We have made significant progress fighting cancer, especially in the last 20 years. This award is a significant motivation for NFCR and a recognition for all our supporters who believe in our journey, even when hope was dim."
NFCR's pathway to this distinguished moment has been both challenging and rewarding. By supporting long-term, high-risk, and high-impact research, NFCR has pursued new frontiers and breakthroughs, providing scientists with the venture and flexible funding to explore and innovate. NFCR has stayed true to the mission of its founders and is committed to finding cures for ALL CANCERS.
"NFCR represents the collective efforts of our researchers, supporters, staff, leadership board, scientific advisors, and cancer fighters worldwide. We can achieve what we have because of our supporters and partners. We greatly appreciate everyone who supports us in our quest for cures," says Dr. Ba.
Dr. Ba and NFCR thank the GFC Awards Gala, the World Brain Mapping Foundation, and the Society for Brain Mapping Therapeutics for this recognition. Looking into the future, Dr. Ba stated, "Doing great science is fantastic, but that's not the end result. Saving people's lives is the ultimate goal. The Pioneer in Medicine Award really energizes me personally and my team to continue to pioneer and push forward the new frontiers for medicine and cancer patients."
About NFCR:
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and Attorney/Business Entrepreneur Franklin Salisbury, Sr. NFCR provides scientists in the lab with the critical seed funding they need to make game-changing discoveries in cancer detection, treatments, prevention, and ultimately, a cure for all cancers. NFCR has distinguished itself in the cancer research sector by emphasizing "high-risk, high-impact" long-term and transformative pioneering research fields often overlooked by other major funding sources. With the support of more than 5.3 million individual donors over the last 51 years, NFCR has provided $410 million in funding to cancer research, prevention, and public education. NFCR-supported research has led to some of the most significant life-saving discoveries that benefit patients today. For more information, please visit www.nfcr.org.
END
COLUMBUS, Ohio – Venting about a source of anger might feel good in the moment, but it’s not effective at reducing the rage, new research suggests.
Instead, techniques often used to address stress – deep breathing, mindfulness, meditation, yoga or even counting to 10 – have been shown to be more effective at decreasing anger and aggression.
Researchers analyzed over 150 studies involving more than 10,000 participants and found that what really works to reduce anger is lowering physiological arousal – in other words, turning down the heat. Activities that increased arousal overall ...
Images
When climate scientists look to the future to determine what the effects of climate change may be, they use computer models to simulate potential outcomes such as how precipitation will change in a warming world.
But University of Michigan scientists are looking at something a little more tangible: coral.
Examining samples from corals in the Great Barrier Reef, the researchers discovered between 1750 and present day, as the global climate warmed, wet-season rainfall in that part of the world increased by about 10%, and the rate of extreme rain events more than doubled. Their results are published in Nature, Communications Earth and Environment.
"Climate scientists ...
An “anti-hunger” molecule produced after vigorous exercise is responsible for the moderate weight loss caused by the diabetes medication metformin, according to a new study in mice and humans. The molecule, lac-phe, was discovered by Stanford Medicine researchers in 2022.
The finding, made jointly by researchers at Stanford Medicine and at Harvard Medical School, further cements the critical role the molecule, called lac-phe, plays in metabolism, exercise and appetite. It may pave the way to a new class of weight loss drugs.
“Until now, the way metformin, which is prescribed to control blood sugar ...
After birth, liver cells acquire different functions depending on their location. CNIO researchers have discovered that this specialization occurs with the onset of oral food intake, which is intermittent.
The alternation of periods with and without nutrients activates the mTOR gene and causes liver cells to specialize, which completes liver maturation.
The finding is the result of an investigation into the consequences of sedentary lifestyles and overeating in today’s society, where the body ...
Scents, such as coffee, flowers, or freshly-baked pumpkin pie, are created by odor molecules released by various substances and detected by our noses. In essence, we are smelling molecules, the basic unit of a substance that retains its physical and chemical properties.
A research team led by Dr. ZHOU Wen from the Institute of Psychology of the Chinese Academy of Sciences has discovered that this process of "smelling" involves an analysis of submolecular structural features.
The study was published online in Nature Human Behaviour on March 18.
In this study, the ...
Anyone who wants to produce medication, plastics or fertilizer using conventional methods needs heat for chemical reactions – but not so with photochemistry, where light provides the energy. The process to achieve the desired product also often takes fewer intermediate steps. Researchers from the University of Basel are now going one step further and are demonstrating how the energy efficiency of photochemical reactions can be increased tenfold. More sustainable and cost-effective applications are now tantalizingly close.
Industrial chemical reactions ...
Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). The study, which compared the characteristics of primary and metastatic tumors, provides new insights into the biology of these aggressive cancers and potential ways to treat them.
In the study, which appeared March 18 in Nature Communications, the researchers examined tissue samples from 44 primary and metastatic UTUC tumors. They compared gene mutations ...
· Temperature sensor warns of disease flareups, tracks disease progression in real time
· Currently no way to quickly detect inflammation, leading to invasive surgeries
· Strategy could be useful in ulcerative colitis, another inflammatory bowel disease
CHICAGO --- A team of Northwestern University scientists has developed the first wireless, implantable temperature sensor to detect inflammatory flareups in patients with Crohn’s disease. The approach offers long-term, real-time monitoring and ...
A new study led by researchers at McLean Hospital (a member of Mass General Brigham) and Washington State University used advances in digital testing to demonstrate that naturally occurring glucose fluctuations impact cognitive function in people with Type 1 Diabetes (T1D). Results showed that cognition was slower in moments when glucose was atypical – that is, considerably higher or lower than someone’s usual glucose level. However, some people were more susceptible to the cognitive effects of large glucose fluctuations than others.
“In trying to understand how diabetes impacts the brain, our research shows that it is important to consider not only how people ...
NEW ORLEANS, March 18, 2024 — Doctors have long prescribed exercise to improve and protect health. In the future, a pill may offer some of the same benefits as exercise. Now, researchers report on new compounds that appear capable of mimicking the physical boost of working out — at least within rodent cells. This discovery could lead to a new way to treat muscle atrophy and other medical conditions in people, including heart failure and neurodegenerative disease.
The researchers will present their ...
